Back to Search
Start Over
The Prevention of the New Onset of Heart Failure in Hypertensive Patients.
- Source :
-
Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jan 01; Vol. 63 (1), pp. 11-15. Date of Electronic Publication: 2022 Oct 19. - Publication Year :
- 2024
-
Abstract
- In 2014, Japan was estimated to have approximately 27 million patients with hypertension (HT), and the ultimate goal of treatment is to prevent complications of HT, including heart failure (HF). The major structural changes in the heart that cause HF are left ventricular (LV) hypertrophy (LVH) and the resulting LV diastolic dysfunction. However, in patients with HT with well-controlled blood pressure (BP), whether they are in HF stage A (only HT) or B (with organic heart disease) is often unclear. It has been reported that strict BP control suppresses LVH, and the improvement of LVH leads to the suppression of cardiovascular complications. Thus, detecting HF stage B HT and providing appropriate treatment lead to the suppression of HF onset. This review focuses on the detection and treatment of organic heart disease in HT.
Details
- Language :
- English
- ISSN :
- 1349-7235
- Volume :
- 63
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Internal medicine (Tokyo, Japan)
- Publication Type :
- Academic Journal
- Accession number :
- 36261381
- Full Text :
- https://doi.org/10.2169/internalmedicine.0799-22